Ledger.Open graph →
SEC Form D · filed February 29, 2024

Cyrus Biotechnology, Inc

Offering
$4.0M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Yifan Song · SEATTLE, WADirectorChad Waite · SEATTLE, WADirectorLucas Nivon · SEATTLE, WAExec · DirectorMark Benjamin · SEATTLE, WAExecLucas Nivon · SEATTLE, WAExec · DirectorMark Benjamin · SEATTLE, WAExecChad Waite · SEATTLE, WADirectorYifan Song · SEATTLE, WADirectorMichael J. Sekits · EL SEGUNDO, CADirectorImran Khan · Morton Grove, ILExecQiao Wang · Morton Grove, ILExec · DirectorSMC Roofing Solutions, LLC · Lawrenceville, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗